Clinical trials
Phase 2/3 Mental Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 5 |
| 2014 | 2 |
| 2017 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tanabe Pharma Corporation | 5 |
| AO GENERIUM | 1 |
| Arizona State University | 1 |
| AstraZeneca | 1 |
| Bo Hu | 1 |
| Center for Research to Practice | 1 |
| Centessa Pharmaceuticals (UK) Limited | 1 |
| Duke University | 1 |
| Edgard Costa de Vilhena | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mental Disorders | 22 |
| Schizophrenia | 5 |
| Nervous System Diseases | 3 |
| Alzheimer Disease | 2 |
| Brain Diseases | 2 |
| Cognitive Dysfunction | 2 |
| Dementia | 2 |
| Neurocognitive Disorders | 2 |
| Neurologic Manifestations | 2 |
| Antisocial Personality Disorder | 1 |
Trials
Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.